Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px

News > All

Total search results: 17221 | Ordered by Date (descending)
1 2 3 ... 171 172 173  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Monocl AB. (7/11/18). "Press Release: Monocl Hires Guy Bowman as Vice President Sales". 2018-07-11
Qiagen N.V.. (7/11/18). "Press Release: Qiagen Partners with U.K. to Expand Biomarker Research in Manchester". Manchester & Hilden. 2018-07-11
Locust Walk Partners, LLC. (7/11/18). "Press Release: Locust Walk Appoints Lubor Gaal as Senior Vice President and Head of Europe to Further Advance Global Expansion of Transactions Business". London & Boston, MA. 2018-07-11
Evolva Holding S.A.. (7/10/18). "Press Release: Evolva Announces Oliver Walker to Succeed Simon Waddington as CEO". 2018-07-10
BioNTech AG. (7/10/18). "Press Release: BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases". Mainz, Cambridge, MA & Basel. 2018-07-10
Summit Therapeutics plc. (7/10/18). "Press Release: Summit Awarded up to $4.5 Million Grant from CARB-X for Development of New Mechanism Gonorrhoea Antibiotics". Oxford & Cambridge, MA. 2018-07-10
Wellcome Trust, The. (7/10/18). "Press Release: Director’s Update. Taking Risks on Bold Idease". 2018-07-10
ProBioGen AG. (7/10/18). "Press Release: ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing Project". Berlin & San Francisco, CA. 2018-07-10
Dynacure S.A.S.. (7/10/18). "Press Release: Dynacure Names Chris Freitag (MD) Chief Medical Officer". Strasbourg. 2018-07-10
TxCell S.A.. (7/9/18). "Press Release: TxCell Exercises In-license Option to the University of British Columbia's Intellectual Property Rights of the HLA-A2 CAR-Treg Program". Valbonne. 2018-07-09
Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London. 2018-07-09
Yposkesi. (7/9/18). "Press Release: Yposkesi Appoints Dr. Fraser Wright as Senior Advisor". Corbeil-Essonnes. 2018-07-09
AMS Biotechnology (Europe) Ltd.. (7/6/18). "Press Release: AMSBIO and University of Strathclyde Jointly Launch New Screening Company". 2018-07-06
Dynacure S.A.S.. (7/6/18). "Press Release: Dynacure Secures €47 Million Financing to Advance Lead Program into Clinical Development". Strasbourg. 2018-07-06
Coulter Partners. (7/5/18). "Press Release: Coulter Partners Secures Chief Executive Officer for Ovizio". 2018-07-05
Coulter Partners. (7/4/18). "Press Release: Coulter Partners Secures Chief Technology Officer for Basilea Pharmaceutica International Ltd.". 2018-07-04
Evotec AG. (7/3/18). "Press Release: Evotec Confirms Closing of Transaction with Sanofi to Accelerate Infectious Disease Research and Development". Hamburg. 2018-07-03
Eurofins Scientific. (7/3/18). "Press Release: Eurofins Announces the Acquisition of Laboratoire de Bromatologie de l’Ouest (LBO) Extending Its Network of Food Testing Laboratories in France". 2018-07-03
NuPharm Group. (7/3/18). "Press Release: NuPharm Group Announces the Acquisition of Laboratoire Biodim in France". Paris. 2018-07-03
Bruker Corporation. (7/3/18). "Press Release: Bruker Announces Acquisition of Lactotronic to Expand Technology and Product Portfolio for Food Analysis in the Dairy Industry". Drachten. 2018-07-03
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
Hookipa Biotech AG. (7/2/18). "Press Release: Hookipa Appoints Dr. Christoph Lengauer as a Non-Executive Director". Vienna. 2018-07-02
Roche. (7/2/18). "Press Release: Roche Commences Tender Offer for All Shares of Foundation Medicine, Inc. for US$ 137.00 per Share in Cash". Basel. 2018-07-02
VarmX B.V.. (7/2/18). "Press Release: VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants". Leiden. 2018-07-02
Abzena plc. (7/2/18). "Press Release: Abzena and Telix Sign Strategic Manufacturing and Bioconjugation Agreement". Cambridge & Melbourne. 2018-07-02
Organobalance GmbH. (7/2/18). "Press Release: Klaus Pellengahr New General Manager of Organobalance-Novozymes Berlin. Professor Dr. Christine Lang Will Continue as a Consultant for Novozymes". Berlin. 2018-07-02
H. Lundbeck A/S. (7/2/18). "Press Release: Dr. Deborah Dunsire Named New President and CEO of Lundbeck". Valby. 2018-07-02
Cytosurge AG. (6/29/18). "Press Release: Partnership between Bruker and Cytosurge – Enabling FluidFM Single Cell Experiments on the BioScope Resolve BioAFM". Zurich / Glattbrugg. 2018-06-29
Deinove S.A.. (6/28/18). "Press Release: Deinove Enters into Collaboration with bioMérieux to Discover New Antibiotics". Montpellier. 2018-06-28
Kymab Ltd.. (6/28/18). "Press Release: Kymab and Roche Clinical Trial Agreement for KY1044". Cambridge. 2018-06-28
Agilent Technologies Inc.. (6/28/18). "Press Release: Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme". Santa Clara, CA. 2018-06-28
Bruker Corporation. (6/28/18). "Press Release: Bruker Launches New Sierra SPR-32 High-Performance Surface Plasmon Resonance System at SLAS Europe 2018". Brussels. 2018-06-28
Bruker Corporation. (6/27/18). "Press Release: Bruker Introduces FluidFM on the BioScope Resolve BioAFM". Santa Barbara, CA. 2018-06-27
ProBioGen AG. (6/26/18). "Press Release: ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Basel. 2018-06-26
Eppendorf AG. (6/26/18). "Press Release: Eppendorf Introduces First Ready-to-use, Synthetic Cell Cultureware for iPSC and MSC Stem Cells". Hamburg. 2018-06-26
H. Lundbeck A/S. (6/25/18). "Press Release: Lundbeck Starts Clinical Development of Potential New Treatment of Parkinson's Disease". Valby. 2018-06-25
Bio-Techne Corporation. (6/25/18). "Press Release: Bio-Techne to Acquire Exosome Diagnostics, Inc.". Minneapolis, MN & Waltham, MA. 2018-06-25
NodThera Ltd.. (6/25/18). "Press Release: NodThera Secures £28 Million ($40 Million) Series A Financing". Cambridge. 2018-06-25
Abivax S.A.. (6/25/18). "Press Release: Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member". Paris. 2018-06-25
Nordic Nanovector ASA. (6/25/18). "Press Release: Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer". Oslo. 2018-06-25
Bruker Corporation. (6/25/18). "Press Release: Bruker Announces Unique New NMR and MS Tools at Metabolomics 2018". Seattle, WA. 2018-06-25
Ovizio Imaging Systems NV/SA. (6/25/18). "Press Release: Ovizio Imaging Systems Appoints Dr. Emilie Viey as Chief Executive Officer". Brussels. 2018-06-25
Evotec AG. (6/25/18). "Press Release: Evotec Achieves Second Milestone in Diabetes Alliance with Sanofi". Hamburg. 2018-06-25
Erytech Pharma. (6/24/18). "Press Release: Erytech Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia". Lyon & Cambridge, MA. 2018-06-24
Boehringer Ingelheim. (6/22/18). "Press Release: Boehringer Ingelheim Bolsters Biologics Research and Development with 230 Million Euro Investment in New Development Center". Biberach. 2018-06-22
Autolus Therapeutics plc. (6/22/18). "Press Release: Autolus Announces Pricing of Initial Public Offering". London. 2018-06-22
Roche. (6/22/18). "Press Release: Changes to the Roche Enlarged Corporate Executive Committee". Basel. 2018-06-22
Silence Therapeutics plc. (6/21/18). "Press Release: Silence Therapeutics Strengthens Board and Leadership Team". 2018-06-21
PhoreMost Ltd.. (6/21/18). "Press Release: PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs". Cambridge. 2018-06-21
Eurofins Scientific. (6/21/18). "Press Release: Eurofins Announces U.S. Antitrust Clearance for the Acquisition of Covance Food Solutions". 2018-06-21
Nanobiotix S.A.. (6/21/18). "Press Release: Nanobiotix Announces Positive Phase II/III Topline Data in Soft Tissue Sarcoma with NBTXR3". Paris & Cambridge, MA. 2018-06-21
AdoRx Therapeutics Ltd.. (6/21/18). "Press Release: AdoRx Therapeutics Announces Initial funding of $10 Million for the Discovery of New Cancer Therapeutics". Edinburgh. 2018-06-21
TxCell S.A.. (6/21/18). "Press Release: First in Vivo Proof-of-Concept Data with CD8+ CAR-Treg Presented at FOCIS 2018". Valbonne. 2018-06-21
iTeos Therapeutics S.A.. (6/20/18). "Press Release: iTeos Therapeutics Completes $75 Million Series B Financing". Gosselies. 2018-06-20
Idorsia Ltd.. (6/20/18). "Press Release: Idorsia Initiates PRECISION Phase 3 Study with Aprocitentan for Resistant Hypertension Management". Allschwil. 2018-06-20
BRAIN AG. (6/20/18). "Press Release: BRAIN AG and CyPlus GmbH Develop Disruptive Technologies for Biological Processing of Precious Metal Ores". Zwingenberg & Hanau. 2018-06-20
Labstep Ltd.. (6/20/18). "Press Release: Seedcamp Backed ScienceTech Startup Labstep Raises £1 Million to Launch Marketplace and Double Its Team". London. 2018-06-20
Novimmune S.A.. (6/20/18). "Press Release: TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody". New York, NY & Geneva. 2018-06-20
Intrexon Corporation. (6/19/18). "Press Release: Oxitec to Apply New Generation of Self-Limiting Mosquito Technology to Malaria-Spreading Mosquitoes". Oxford. 2018-06-19
UgiSense AG. (6/19/18). "Press Release: UgiSense AG Secures New Financing". Dortmund. 2018-06-19
Sanofi S.A.. (6/19/18). "Press Release: Sanofi Appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer". Paris. 2018-06-19
Merck KGaA. (6/19/18). "Press Release: Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology". Darmstadt. 2018-06-19
Freeline Therapeutics Ltd.. (6/19/18). "Press Release: Freeline Secures Over £88 Million of Funding". London. 2018-06-19
Galmed Pharmaceuticals Ltd.. (6/19/18). "Press Release: Galmed Pharmaceuticals Ltd. Announces Pricing of Public Offering of Ordinary Shares". Tel Aviv. 2018-06-19
Roche. (6/19/18). "Press Release: Roche and Foundation Medicine Reach Definitive Merger Agreement to Accelerate Broad Availability of Comprehensive Genomic Profiling in Oncology". Basel. 2018-06-19
Sanofi S.A.. (6/19/18). "Press Release: Sanofi Completes Its Acquisition of Ablynx Following the Expiration of the Squeeze-out Procedure". Paris & Ghent. 2018-06-19
Enamine Ltd.. (6/19/18). "Press Release: Enamine and TBD Biodiscovery Collaborate to Provide GMP-based Services". Kiev & Tartu. 2018-06-19
Idorsia Ltd.. (6/18/18). "Press Release: Idorsia Is Initiating REACT - Phase 3 Registration Study with Clazosentan". Allschwil. 2018-06-18
Crescendo Biologics Ltd.. (6/18/18). "Press Release: Crescendo Biologics Appoints Eva-Lotta Allan as Non-Executive Director". Cambridge. 2018-06-18
Galmed Pharmaceuticals Ltd.. (6/18/18). "Press Release: Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares". Tel Aviv. 2018-06-18
Evotec AG. (6/18/18). "Press Release: Evotec and Sanofi Sign Definitive Agreement to Combat Infectious Disease". Hamburg. 2018-06-18
Sophia Genetics S.A.. (6/16/18). "Press Release: Sophia Genetics Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World". Milan. 2018-06-16
Noxxon Pharma N.V.. (6/15/18). "Press Release: Noxxon Announces that It Has Secured Additional Financing". Berlin. 2018-06-15
Deinove S.A.. (6/15/18). "Press Release: Successful Capital Increase €8.5 Million [Not for United States, Canada, Australia and Japan]". Montpellier. 2018-06-15
Erytech Pharma. (6/15/18). "Press Release: Erytech to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018". Lyon. 2018-06-15
Teva Pharmaceutical Industries Ltd.. (6/15/18). "Press Release: Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache". Jerusalem. 2018-06-15
GlaxoSmithKline plc. (6/14/18). "Press Release: ViiV Healthcare Reports Landmark Phase III Studies for Dolutegravir and Lamivudine, Demonstrating the Ability to Control HIV with a Two-Drug Regimen in Treatment Naïve Patients". London. 2018-06-14
Deinove S.A.. (6/14/18). "Press Release: Deinove Announces the Launch of a Capital Increase through an Accelerated Book Building [Not for United States, Canada, Australia and Japan]". Montpellier. 2018-06-14
Forbion Capital Partners. (6/14/18). "Press Release: Dirk Kersten Joins Forbion as General Partner". Naarden. 2018-06-14
Adrenomed AG. (6/14/18). "Press Release: Adrenomed AG Reveals Adrecizumab Mode of Action". Hennigsdorf. 2018-06-14
Cellnovo. (6/14/18). "Press Release: Cellnovo Announces the Commercialisation of Insulin Cartridges Following the Successful Start of Large-scale Manufacturing at the Flex Facility in Althofen, Austria". Paris. 2018-06-14
Philips. (6/13/18). "Press Release: Philips Expands Its Therapeutic Care Business with the Acquisition of Remote Diagnostic Technologies". Amsterdam. 2018-06-13
Uniqure N.V.. (6/13/18). "Press Release: Uniqure Announces New Appointments to its Board of Directors". Lexington, MA & Amsterdam. 2018-06-13
British Business Bank. (6/13/18). "Press Release: £2.5bn British Patient Capital Programme Launched to Enable Long-term Investment in Innovative Companies across the UK". 2018-06-13
Mologic Ltd.. (6/13/18). "Press Release: Mologic and Newcastle University Launch BReD Diagnostic for Blackgrass Resistance at Cereals". Bedfordshire & Newcastle. 2018-06-13
TiGenix N.V.. (6/13/18). "Press Release: TiGenix Announces a Change in Its Board of Directors and Its Management Team". Leuven. 2018-06-13
Gendoktorn Medicinsk Service i Göteborg AB. (6/12/18). "Press Release: The Gene Doctor and Abomics Open Pharmacogenetic Service in Sweden". 2018-06-12
MorphoSys AG. (6/12/18). "Press Release: New Phase 3 Clinical Trials by MorphoSys’s Partner with Gantenerumab in Early Alzheimer's Disease now Underway". Planegg. 2018-06-12
Bruker Corporation. (6/12/18). "Press Release: Bruker Introduces New Skyscan 2214 Ultra-High Resolution Nano-CT". Billerica. 2018-06-12
AstraZeneca plc. (6/12/18). "Press Release: Update on Phase III Clinical Trials of Lanabecestat for Alzheimer’s Disease. Independent Data Monitoring Committee Advises Lanabecestat Is Unlikely to Meet Primary Endpoints, Leading to Decision to Discontinue 2018-06-12
Cellectis S.A.. (6/12/18). "Press Release: Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports". New York. 2018-06-12
CureVac AG. (6/12/18). "Press Release: CureVac Announces Appointment of Matthew L. S. Beck as Vice President of Investor Relations". Tübingen & Boston, MA. 2018-06-12
Bluebee. (6/12/18). "Press Release: Lexogen and Bluebee Collaborate to Streamline QuantSeq-UMI Sequencing Data Analysis Pipeline". Vienna & Rijswijk. 2018-06-12
Advanced Chemistry Development, Inc. (ACD/Labs). (6/12/18). "Press Release: The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management Strategy". Toronto. 2018-06-12
Sartorius AG. (6/12/18). "Press Release: Sartorius Stedim Biotech and Siemens Sign Long-Term Cooperation Agreement in the Area of Automation". Göttingen & Munich. 2018-06-12
Andrew Alliance S.A.. (6/12/18). "Press Release: Andrew Alliance Raises $14m from Top Life Sciences Industry Partners and Global Investors". Geneva. 2018-06-12
Targovax ASA. (6/11/18). "Press Release: Targovax Strengthens Focus on ONCOS Oncolytic Virus Development Program". Oslo. 2018-06-11
Themis Bioscience GmbH. (6/11/18). "Press Release: Themis Receives EMA PRIME Designation for Chikungunya Vaccine". Vienna. 2018-06-11
Memo Therapeutics AG. (6/11/18). "Press Release: Memo Therapeutics AG Announced that Dr. Karsten Fischer Was Appointed as Chief Executive Officer of the Company Effective June 01, 2018". Basel. 2018-06-11
Idorsia Ltd.. (6/11/18). "Press Release: Idorsia Initiates a Phase 3 Registration Program with Nemorexant (ACT-541468) for the Treatment of Insomnia". Allschwil. 2018-06-11
1 2 3 ... 171 172 173  next pagenext page



Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px

» top